290 related articles for article (PubMed ID: 23453280)
1. Topical linezolid 0.2% for the treatment of vancomycin-resistant or vancomycin-intolerant gram-positive bacterial keratitis.
Tu EY; Jain S
Am J Ophthalmol; 2013 Jun; 155(6):1095-1098.e1. PubMed ID: 23453280
[TBL] [Abstract][Full Text] [Related]
2. Treatment of prosthetic valve infective endocarditis due to multi-resistant Gram-positive bacteria with linezolid.
Wareham DW; Abbas H; Karcher AM; Das SS
J Infect; 2006 Apr; 52(4):300-4. PubMed ID: 16099052
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of linezolid in liver transplant patients.
Radunz S; Juntermanns B; Kaiser GM; Treckmann J; Mathe Z; Paul A; Saner FH
Transpl Infect Dis; 2011 Aug; 13(4):353-8. PubMed ID: 21355969
[TBL] [Abstract][Full Text] [Related]
4. The clinical impact of linezolid susceptibility reporting in patients with vancomycin-resistant enterococci.
Scheetz MH; Qi C; Noskin GA; Warren JR; Postelnick MJ; Malczynski M; Huang J; Zembower TR
Diagn Microbiol Infect Dis; 2006 Dec; 56(4):407-13. PubMed ID: 16930924
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility to tigecycline and linezolid among gram-positive isolates collected in the United States as part of the tigecycline evaluation and surveillance trial (TEST) between 2004 and 2009.
Dowzicky MJ
Clin Ther; 2011 Dec; 33(12):1964-73. PubMed ID: 22078154
[TBL] [Abstract][Full Text] [Related]
6. Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus keratitis in rabbits.
Tas T; Kucukbayrak A; Hakyemez IN; Mengeloglu FZ; Simavli H; Ozyalvacli G; Erdurmus M
Cornea; 2013 Jul; 32(7):1052-7. PubMed ID: 23665649
[TBL] [Abstract][Full Text] [Related]
7. Short-term success, but long-term treatment failure with linezolid for enterococcal endocarditis.
Berdal JE; Eskesen A
Scand J Infect Dis; 2008; 40(9):765-6. PubMed ID: 18609208
[TBL] [Abstract][Full Text] [Related]
8. [The first clinical experiences in Hungary with a new effective antibiotic (linezolid) effective against Gram-positive infections].
Pulay I; Konkoly TM; Zsirka KA; Csapó Z; Flautner L; Tihanyi T
Orv Hetil; 2003 Jan; 144(1):29-33. PubMed ID: 12635350
[TBL] [Abstract][Full Text] [Related]
9. Vancomycin-resistant Enterococcus faecalis endocarditis: linezolid failure and strain characterization of virulence factors.
Tsigrelis C; Singh KV; Coutinho TD; Murray BE; Baddour LM
J Clin Microbiol; 2007 Feb; 45(2):631-5. PubMed ID: 17182759
[TBL] [Abstract][Full Text] [Related]
10. Use of linezolid, an oxazolidinone, in the treatment of multidrug-resistant gram-positive bacterial infections.
Chien JW; Kucia ML; Salata RA
Clin Infect Dis; 2000 Jan; 30(1):146-51. PubMed ID: 10619743
[TBL] [Abstract][Full Text] [Related]
11. Incidence and clinical characteristics of enterococcus keratitis.
Rau G; Seedor JA; Shah MK; Ritterband DC; Koplin RS
Cornea; 2008 Sep; 27(8):895-9. PubMed ID: 18724150
[TBL] [Abstract][Full Text] [Related]
12. Experience with linezolid therapy in children with osteoarticular infections.
Chen CJ; Chiu CH; Lin TY; Lee ZL; Yang WE; Huang YC
Pediatr Infect Dis J; 2007 Nov; 26(11):985-8. PubMed ID: 17984803
[TBL] [Abstract][Full Text] [Related]
13. Predictors and outcomes of linezolid-resistant vancomycin-resistant Enterococcus: a case-case-control study.
Hayakawa K; Marchaim D; Pogue JM; Ho K; Parveen S; Nanjireddy P; Sunkara B; Singla M; Jagadeesh KK; Moshos JA; Bommarito S; Mroue R; Farhat M; Obeid T; Chaudhry A; Vadlamudi G; Lephart PR; Martin ET; Rybak MJ; Kaye KS
Am J Infect Control; 2012 Dec; 40(10):e261-3. PubMed ID: 23199727
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment of vancomycin-resistant Enterococcus endocarditis with oral linezolid.
Babcock HM; Ritchie DJ; Christiansen E; Starlin R; Little R; Stanley S
Clin Infect Dis; 2001 May; 32(9):1373-5. PubMed ID: 11303275
[TBL] [Abstract][Full Text] [Related]
15. Impact of the more-potent antibiotics quinupristin-dalfopristin and linezolid on outcome measure of patients with vancomycin-resistant Enterococcus bacteremia.
Erlandson KM; Sun J; Iwen PC; Rupp ME
Clin Infect Dis; 2008 Jan; 46(1):30-6. PubMed ID: 18171210
[TBL] [Abstract][Full Text] [Related]
16. Linezolid in the treatment of vancomycin-resistant Enterococcus faecium in solid organ transplant recipients: report of a multicenter compassionate-use trial.
El-Khoury J; Fishman JA
Transpl Infect Dis; 2003 Sep; 5(3):121-5. PubMed ID: 14617299
[TBL] [Abstract][Full Text] [Related]
17. Comparison of outcomes from daptomycin or linezolid treatment for vancomycin-resistant enterococcal bloodstream infection: A retrospective, multicenter, cohort study.
Crank CW; Scheetz MH; Brielmaier B; Rose WE; Patel GP; Ritchie DJ; Segreti J
Clin Ther; 2010 Sep; 32(10):1713-9. PubMed ID: 21194593
[TBL] [Abstract][Full Text] [Related]
18. Intraventricular daptomycin and intravenous linezolid for the treatment of external ventricular-drain-associated ventriculitis due to vancomycin-resistant Enterococcus faecium.
Mueller SW; Kiser TH; Anderson TA; Neumann RT
Ann Pharmacother; 2012 Dec; 46(12):e35. PubMed ID: 23232018
[TBL] [Abstract][Full Text] [Related]
19. A case of vancomycin-resistant enterococcus conjunctivitis and its clinically successful topical treatment.
Maguen E; Morgan MA
Cornea; 2007 Feb; 26(2):223-4. PubMed ID: 17251818
[TBL] [Abstract][Full Text] [Related]
20. [Linezolid therapy for infectious endocarditis].
Lauridsen TK; Arpi M; Bruun NE
Ugeskr Laeger; 2010 Apr; 172(16):1215-6. PubMed ID: 20423667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
